Search results
PROMOTED
Rhythm Interventions Online is back! Mark your calendars for Thursday 20 and Friday 21 November, as we bring you the most dynamic and immersive virtual experience in electrophysiology and cardiac rhythm management.
After five hugely successful editions, RIO has cemented its place as a must-attend global event, delivering world-class education to thousands of healthcare professionals worldwide.
…
View more
RIO 2025 - Day One | Global
Author(s):
Devi Nair
,
Richard Schilling
,
Roderick Tung
,
et al
Start date:
Nov 20, 2025
Broadcast
Author(s):
Rahul Aggarwal
,
Dirk Müller-Wieland
Added:
2 months ago
Filmed onsite at EASD 2025, this on-demand series features key insights from Prof Dirk Müller-Wieland and Dr Rahul Aggarwal to interpret the latest data on eicosapentaenoic acid(EPA), including the latest sub-analysis of the REDUCE-IT trial, whichanalysed the effectiveness of icosapent ethyl (IPE) on CV risk by triglyceride-glucose (TyG) index - an indicator of insulin resistance and risk of type…
View more
Author(s):
Tim R Betts
,
Patrick A Calvert
,
Lee N Graham
,
et al
Added:
1 year ago
Author(s):
Christian-Hendrik Heeger
,
Natig Gassanov
,
Mirza Mutallimov
Added:
1 month ago
Roland Asmar
Job title: President, Foundation–Medical Research Institutes, Geneva and Professor, Lebanese University of Medicine, Beirut
Author
George L Bakris
Job title: President Elect
Author
Author(s):
Mark T Mills
,
Thomas A Slater
,
Ashley Nisbet
,
et al
Added:
2 months ago
Author(s):
Ahran D Arnold
Added:
3 months ago
ESC Congress 2025 - EMORI-HCM finds that right ventricular pacing (iRVP) improves symptoms in obstructive hypertrophic cardiomyopathy (oHCM) patients.Dr Ahran Arnold (Imperial College London, UK) discusses findings from the EMORI-HCM study, exploring electro-mechanically optimised right ventricular pacing as a novel therapeutic approach for patients with oHCM.This interventional trial examined…
View more
Added:
4 months ago
Source:
Radcliffe Cardiology
The long-term utility of beta-blockers following an uncomplicated myocardial infarction (MI) remains a subject of clinical debate. New secondary results from the AβYSS trial (Assessment of β-blocker interruption one Year after an uncomplicated myocardial infarction on Safety and Symptomatic cardiac events requiring hospitalization) reveal that interrupting this therapy leads to sustained…
View more
Author(s):
Gerhard Hindricks
,
Faizel Osman
,
Keitaro Senoo
,
et al
Added:
2 years ago
This video series page covers content associated with Atrial Fibrillation.AFib is associated with a 5x greater risk of stroke, however with effective treatment, the risk of stroke can be reduced.¹ The lifetime risk for AFib is 1 in 3 individuals² and it often occurs with hypertension. Early detection is key, to allow for prompt and satisfactory disease management to not only control symptoms but…
View more